Today: 11 June 2026
Goldman Sachs stock jumps on earnings beat and dividend hike as traders cash in on volatility
15 January 2026
2 mins read

Goldman Sachs stock jumps on earnings beat and dividend hike as traders cash in on volatility

New York, January 15, 2026, 11:21 ET — Regular session

  • Goldman Sachs shares rose about 4% after fourth-quarter profit beat estimates.
  • Equities trading revenue hit a record $4.31 billion; investment banking fees rose 25% to $2.58 billion.
  • Investors are watching costs and whether 2026 dealmaking momentum holds.

Goldman Sachs shares rose nearly 4% on Thursday after the Wall Street bank topped fourth-quarter profit estimates and raised its dividend. The stock was up about 3.9% at $969.24, after closing at $932.67 on Wednesday.

The results land as investors comb through bank earnings for signs that last year’s revival in dealmaking can stick, even as rate-cut bets and market swings keep changing the tone. For Goldman, the big question is whether a hot run in trading and advisory can carry into 2026 without costs catching up.

Goldman said earnings per share came in at $14.01, beating analysts’ estimate of $11.67, helped by a surge in trading revenue and stronger investment-banking activity. Equities revenue rose to a record $4.31 billion, while fixed income, currencies and commodities (FICC) — the bond and macro trading business — brought in $3.11 billion.

Still, expectations were high after a sharp run in the stock last year. “The stock has been on a tear,” RBC Capital Markets analyst Gerard Cassidy said, adding that the results “met a high bar,” while Argus Research analyst Stephen Biggar called the dividend increase a “powerful testament” to confidence in earnings. Reuters

Chief Executive David Solomon struck a confident tone in the firm’s earnings presentation, saying Goldman expects “momentum to accelerate in 2026,” while stressing “disciplined risk management” as it looks for places to deploy capital and return it to shareholders. SEC

Goldman reported fourth-quarter net revenues of $13.45 billion and net earnings of $4.62 billion, and posted full-year net revenues of $58.28 billion with net earnings of $17.18 billion. The bank said its board raised the quarterly dividend to $4.50 per share from $4.00, payable on March 30 to shareholders of record on March 2, and that it returned $16.78 billion to common shareholders in 2025, including $12.36 billion of share repurchases.

Wealth is becoming a bigger part of the pitch. Goldman said assets under supervision — the money it manages or oversees for clients — climbed to a record $3.61 trillion, while management fees hit a quarterly record as the firm pushed for steadier, fee-based income.

Investment banking fees rose 25% to $2.58 billion as mergers and acquisitions picked up, though the figure was slightly below analysts’ expectations. Goldman also flagged a rebound in initial public offerings (IPOs), with bankers looking toward a busier 2026 pipeline after a choppy stretch.

The consumer unwind was still visible in the numbers. The bank pointed to a $2.26 billion markdown tied to the transition of the Apple Card loans, offset by a $2.48 billion reserve reduction in provisions for credit losses.

Costs remain a live issue. Operating expenses rose 18% to $9.72 billion in the quarter, with Goldman citing higher compensation and investments, including work on artificial intelligence tools inside the firm.

That leaves a narrower margin for error if markets cool. Trading results can fade quickly when volatility drops, and advisory fees still depend on companies actually closing deals — a process that can stall if financing costs rise or confidence slips.

Investors are now watching for follow-through across the rest of bank earnings and for the Federal Reserve’s next policy meeting on January 27–28, a key marker for rate expectations that can move trading volumes and deal timing.

Stock Market Today

  • SpaceX IPO Receives Over $70 Billion in Retail Demand
    June 11, 2026, 10:07 AM EDT. SpaceX's initial public offering (IPO) has garnered more than $70 billion in orders from retail investors, sources said. This surge in demand positions the offering for a potentially record-breaking debut as it moves toward completion. The strong retail interest underscores SpaceX's significant appeal in equity markets and highlights investor confidence in its space exploration and satellite ventures.

Latest articles

Navan surges after guidance hike brings AI travel platform to fore

Navan surges after guidance hike brings AI travel platform to fore

11 June 2026
Navan shares soared 21.18% premarket to $25.29 after the company raised its fiscal 2027 revenue outlook to $907–$913 million and boosted its non-GAAP operating income forecast to $76–$80 million, citing strong enterprise demand and surging booking volume, even as GAAP losses and cash burn persist.
Quantum Cyber slips after QUCY drone unit plan raises dilution fears

Quantum Cyber slips after QUCY drone unit plan raises dilution fears

11 June 2026
Quantum Cyber unveiled plans for an Advanced Filament Manufacturing Division at its proposed Connecticut drone facility, aiming to supply its 3D-printer drone farm and sell EMP-hardened filament, as QUCY shares closed at $1.92 on June 10 and rose 3.65% premarket amid volatile, high-volume trading; investors now weigh execution risks, ongoing losses, and the need for fresh capital against the company’s strategic manufacturing pivot.
Alibaba Drops After Beijing Puts 618 Subsidies in the Spotlight

Alibaba Drops After Beijing Puts 618 Subsidies in the Spotlight

11 June 2026
Alibaba’s Hong Kong shares plunged 5.4% after Beijing regulators challenged Taobao and Tmall’s 6.18 shopping festival discount claims, intensifying regulatory risk just as U.S.-listed shares had fallen for six straight sessions and raising investor concerns over profit margins and future promotions.
POET Technologies stock climbs before the bell as call-option volume spikes
Previous Story

POET Technologies stock climbs before the bell as call-option volume spikes

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop